Methyl 3,6-Dibromopyrazine-2-carboxylate (CAS 13301-04-7): A High-Purity Pharmaceutical Intermediate
Discover the high-purity chemical backbone essential for accelerating your pharmaceutical innovations and advanced drug synthesis projects.
Get a Quote & SampleUnlocking Innovation in Pharmaceutical Chemistry
Methyl 3,6-Dibromopyrazine-2-carboxylate
Methyl 3,6-Dibromopyrazine-2-carboxylate is a critical and versatile chemical intermediate, indispensable in the synthesis of complex pharmaceutical compounds. Its unique molecular structure, featuring two bromine atoms and a pyrazine core, makes it an invaluable building block for creating novel active pharmaceutical ingredients (APIs) and advanced medicinal research molecules. This compound ensures precision and efficiency in your synthesis workflows.
- High-Purity Assurance: We ensure a minimum 95% purity for our high purity Methyl 3,6-Dibromopyrazine-2-carboxylate, crucial for sensitive pharmaceutical synthesis, meeting stringent industry standards.
- Stable Chemical Profile: Enjoy reliable and consistent performance as this compound demonstrates excellent stability under normal temperatures and pressures, vital for storage and reaction integrity.
- Key API Building Block: As a leading supplier of Methyl 3,6-Dibromopyrazine-2-carboxylate, we provide the foundational chemical required for the efficient manufacturing of essential active pharmaceutical ingredients for API synthesis.
- Advanced Research Utility: Ideal for medicinal chemistry research and development, supporting the exploration and creation of novel therapeutic compounds, enabling the next generation of drugs.
Key Advantages for Your Synthesis Projects
Purity and Reliability
Our Methyl 3,6-Dibromopyrazine-2-carboxylate offers a minimum purity of 95%, ensuring reliable outcomes for your sensitive organic synthesis building blocks applications. This high standard minimizes impurities and streamlines your downstream processes.
Consistent Performance
Characterized by excellent stability under standard conditions, this compound provides consistent performance, critical for reproducible results in pharmaceutical intermediates development and large-scale production.
Versatile Reactivity
The unique dibromopyrazine structure of this compound makes it a versatile chemical tool for various reactions, particularly valuable when exploring new pyrazine derivatives for drug discovery.
Key Applications
Pharmaceutical Manufacturing
Methyl 3,6-Dibromopyrazine-2-carboxylate is extensively utilized in the synthesis of a broad spectrum of pharmaceutical products, acting as a crucial intermediate for drug synthesis, from small-molecule therapeutics to complex APIs.
Medicinal Chemistry Research
Researchers leverage this compound in medicinal chemistry research for developing new drug candidates. Its reactive sites allow for the creation of novel compounds with potential therapeutic benefits.
API Precursor Synthesis
It serves as a direct precursor in the synthesis of various Active Pharmaceutical Ingredients (APIs), facilitating the creation of essential components for medical treatments. Many companies seek to buy 13301-04-7 pharmaceutical intermediate for these critical production lines.
Specialty Chemical Development
This compound is also a cornerstone in the development of specialty heterocyclic compounds, enabling innovators to create advanced materials for a range of high-tech applications, leveraging its unique molecular framework.